The Impact of Incubators on Venture Investing
This article was originally published in Start Up
Executive Summary
It seems logical that an incubator should facilitate venture fund investment in early-stage biomedical companies, since the incubator should accelerate technology commercialization. Unfortunately, few incubators--at least on the biotech side--have realized this potential, for a variety of reasons.
You may also be interested in...
Innovating on Biotech Investment Models: Likely--or Even Possible?
With the lack of a public market, VCs have grown extremely chary of new investments: are there lessons to be learned for biotech investing from the models employed by device investors or other apparently lower-risk approaches, such as "defined liquidity ventures"?
The Comparative Advantages of Medical Device Investing
Given the currently dismal valuations of public biotechnology companies and with no near-term expectation of an upturn in investor appetites, venture funds are increasingly interested in medical device investing thanks to their lower capital costs and likely exits via acquisitions.
The Comparative Advantages of Medical Device Investing
Given the currently dismal valuations of public biotechnology companies and with no near-term expectation of an upturn in investor appetites, venture funds are increasingly interested in medical device investing thanks to their lower capital costs and likely exits via acquisitions.